1. Home
  2. CACI vs LNTH Comparison

CACI vs LNTH Comparison

Compare CACI & LNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CACI
  • LNTH
  • Stock Information
  • Founded
  • CACI 1962
  • LNTH 1956
  • Country
  • CACI United States
  • LNTH United States
  • Employees
  • CACI N/A
  • LNTH N/A
  • Industry
  • CACI EDP Services
  • LNTH Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • Sector
  • CACI Technology
  • LNTH Health Care
  • Exchange
  • CACI Nasdaq
  • LNTH Nasdaq
  • Market Cap
  • CACI 7.3B
  • LNTH 7.5B
  • IPO Year
  • CACI 1979
  • LNTH 2015
  • Fundamental
  • Price
  • CACI $479.45
  • LNTH $81.24
  • Analyst Decision
  • CACI Buy
  • LNTH Strong Buy
  • Analyst Count
  • CACI 13
  • LNTH 5
  • Target Price
  • CACI $502.83
  • LNTH $133.80
  • AVG Volume (30 Days)
  • CACI 369.5K
  • LNTH 1.4M
  • Earning Date
  • CACI 04-23-2025
  • LNTH 05-07-2025
  • Dividend Yield
  • CACI N/A
  • LNTH N/A
  • EPS Growth
  • CACI 22.32
  • LNTH N/A
  • EPS
  • CACI 21.19
  • LNTH 3.53
  • Revenue
  • CACI $8,361,975,000.00
  • LNTH $1,536,699,000.00
  • Revenue This Year
  • CACI $14.65
  • LNTH $4.96
  • Revenue Next Year
  • CACI $7.25
  • LNTH $10.25
  • P/E Ratio
  • CACI $22.56
  • LNTH $23.00
  • Revenue Growth
  • CACI 14.16
  • LNTH 12.53
  • 52 Week Low
  • CACI $318.60
  • LNTH $74.34
  • 52 Week High
  • CACI $588.26
  • LNTH $126.89
  • Technical
  • Relative Strength Index (RSI)
  • CACI 71.28
  • LNTH 32.82
  • Support Level
  • CACI $460.14
  • LNTH $77.01
  • Resistance Level
  • CACI $483.10
  • LNTH $83.60
  • Average True Range (ATR)
  • CACI 10.82
  • LNTH 3.77
  • MACD
  • CACI -1.12
  • LNTH -2.21
  • Stochastic Oscillator
  • CACI 91.09
  • LNTH 13.26

About CACI CACI International Inc.

CACI International Inc is an information solutions and services provider, offering information solutions and services to its customers. The company's primary customers are agencies and departments of the U.S. government, which account for the vast majority of the firm's revenue. It provides information solutions and services supporting national security missions and government modernization for intelligence, defense, and federal civilian customers. Some of the services provided by the company are functional software development, data, and business analysis, IT operations support, naval architecture, and life cycle support intelligence among others. The company's operating segments are; Domestic operations and International operations. It derives key revenue from the Domestic segment.

About LNTH Lantheus Holdings Inc.

Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.

Share on Social Networks: